Inicio > The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens
28/02/2011

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens

0

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article
P. J. Bousquet, M.A. Calderón, P.Demoly, D. Larenas, G. Passalacqua, C. Bachert, J. Brozek, G.W. Canonica, T. Casale, J. Fonseca, R. Dahl, S.R. Durham, H. Merk, M. Worm, U. Wahn, T. Zuberbier, H.J. Schünemann, J. Bousquet. Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 49-56.e11, January 2011.

feb 28th, 2011. En: Ámbito regulatorio #

Haga un comentario

Los campos con asteriscos (*) son obligatorios.

*

code